High-Throughput Profiling of Candida auris Isolates Reveals Clade-Specific Metabolic Differences

Four main clades of the emerging, multidrug-resistant human pathogen Candida auris have been identified, and they differ in their susceptibilities to antifungals and disinfectants. Moreover, clade- and strain-specific metabolic differences have been identified, but a comprehensive overview of nutritional characteristics and resistance to various stressors is missing. ABSTRACT Candida auris, a multidrug-resistant human fungal pathogen that causes outbreaks of invasive infections, emerged as four distinct geographical clades. Previous studies identified genomic and proteomic differences in nutrient utilization on comparison to Candida albicans, suggesting that certain metabolic features may contribute to C. auris emergence. Since no high-throughput clade-specific metabolic characterization has been described yet, we performed a phenotypic screening of C. auris strains from all 4 clades on 664 nutrients, 120 chemicals, and 24 stressors. We identified common and clade- or strain-specific responses, including the preferred utilization of various dipeptides as nitrogen source and the inability of the clade II isolate AR 0381 to withstand chemical stress. Further analysis of the metabolic properties of C. auris isolates showed robust growth on intermediates of the tricarboxylic acid cycle, such as citrate and succinic and malic acids. However, there was reduced or no growth on pyruvate, lactic acid, or acetate, likely due to the lack of the monocarboxylic acid transporter Jen1, which is conserved in most pathogenic Candida species. Comparison of C. auris and C. albicans transcriptomes of cells grown on alternative carbon sources and dipeptides as a nitrogen source revealed common as well as species-unique responses. C. auris induced a significant number of genes with no ortholog in C. albicans, e.g., genes similar to the nicotinic acid transporter TNA1 (alternative carbon sources) and to the oligopeptide transporter (OPT) family (dipeptides). Thus, C. auris possesses unique metabolic features which could have contributed to its emergence as a pathogen. IMPORTANCE Four main clades of the emerging, multidrug-resistant human pathogen Candida auris have been identified, and they differ in their susceptibilities to antifungals and disinfectants. Moreover, clade- and strain-specific metabolic differences have been identified, but a comprehensive overview of nutritional characteristics and resistance to various stressors is missing. Here, we performed high-throughput phenotypic characterization of C. auris on various nutrients, stressors, and chemicals and obtained transcriptomes of cells grown on selected nutrients. The generated data sets identified multiple clade- and strain-specific phenotypes and induction of C. auris-specific metabolic genes, showing unique metabolic properties. The presented work provides a large amount of information for further investigations that could explain the role of metabolism in emergence and pathogenicity of this multidrug-resistant fungus.

[1]  D. Stevens,et al.  Initial Results of the International Efforts in Screening New Agents against Candida auris , 2022, Journal of fungi.

[2]  P. Escandón Novel Environmental Niches for Candida auris: Isolation from a Coastal Habitat in Colombia , 2022, Journal of fungi.

[3]  R. V. Prasad,et al.  Genome-wide analysis of PTR transporters in Candida species and their functional characterization in Candida auris , 2022, Applied Microbiology and Biotechnology.

[4]  Sascha Schäuble,et al.  Candida albicans SR-Like Protein Kinases Regulate Different Cellular Processes: Sky1 Is Involved in Control of Ion Homeostasis, While Sky2 Is Important for Dipeptide Utilization , 2022, Frontiers in Cellular and Infection Microbiology.

[5]  S. Brunke,et al.  From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris , 2022, Virulence.

[6]  R. V. Prasad,et al.  Fluconazole resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor , 2022, Cell surface.

[7]  M. Lorenz,et al.  GNP2 Encodes a High-Specificity Proline Permease in Candida albicans , 2022, mBio.

[8]  Michael Y. Lin,et al.  Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility , 2021, Nature Medicine.

[9]  F. Sadeghi,et al.  New weapons to fight a new enemy: A systematic review of drug combinations against the drug‐resistant fungus Candida auris , 2021, Mycoses.

[10]  A. Chowdhary,et al.  Environmental Isolation of Candida auris from the Coastal Wetlands of Andaman Islands, India , 2021, mBio.

[11]  E. Berkow,et al.  Antifungal activity of nikkomycin Z against Candida auris. , 2021, The Journal of antimicrobial chemotherapy.

[12]  Christina A. Cuomo,et al.  Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance , 2020, mBio.

[13]  M. Lorenz,et al.  Carboxylic Acid Transporters in Candida Pathogenesis , 2020, mBio.

[14]  Rhys A. Farrer,et al.  Nine Things Genomics Can Tell Us About Candida auris , 2020, Frontiers in Genetics.

[15]  Alistair J. P. Brown,et al.  The environmental stress sensitivities of pathogenic Candida species, including Candida auris, and implications for their spread in the hospital setting , 2020, Medical mycology.

[16]  S. Lockhart Candida auris and multidrug resistance: defining the new normal. , 2019, Fungal genetics and biology : FG & B.

[17]  H. Badali,et al.  Potential Fifth Clade of Candida auris, Iran, 2018 , 2019, Emerging infectious diseases.

[18]  R. Garduño,et al.  Determination of antimicrobial effect of protamine by transmission electron microscopy and SDS PAGE on Pseudomonas aeruginosa isolates from diabetic foot infection , 2019, Iranian journal of basic medical sciences.

[19]  Craig Williams,et al.  Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence. , 2019, The Journal of hospital infection.

[20]  Sneha P. Couvillion,et al.  Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen , 2019, mSystems.

[21]  Christina A. Cuomo,et al.  Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species , 2018, Nature Communications.

[22]  Guanghua Huang,et al.  The first isolate of Candida auris in China: clinical and biological aspects , 2018, Emerging Microbes & Infections.

[23]  A. Chowdhary,et al.  A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance , 2018, The Journal of antimicrobial chemotherapy.

[24]  J. Osei Sekyere,et al.  Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen , 2018, MicrobiologyOpen.

[25]  H. Guo,et al.  Involvement of mitochondrial aerobic respiratory activity in efflux-mediated resistance of C. albicans to fluconazole. , 2017, Journal de mycologie medicale.

[26]  L. Rose,et al.  Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface , 2017, Journal of Clinical Microbiology.

[27]  Christina A. Cuomo,et al.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Matthew Fisher,et al.  First hospital outbreak of the globally emerging Candida auris in a European hospital , 2016, Antimicrobial Resistance & Infection Control.

[29]  A. Chowdhary,et al.  Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  A. Chowdhary,et al.  Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method , 2015, Journal of Clinical Microbiology.

[31]  Jukka Corander,et al.  Novel R Pipeline for Analyzing Biolog Phenotypic Microarray Data , 2015, PloS one.

[32]  C. Adams,et al.  Trifluoperazine versus placebo for schizophrenia. , 2014, The Cochrane database of systematic reviews.

[33]  A. Chowdhary,et al.  Multidrug-resistant endemic clonal strain of Candida auris in India , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[34]  Benjamin Hofner,et al.  opm: an R package for analysing OmniLog® phenotype microarray data , 2013, Bioinform..

[35]  A. Gunasekera,et al.  N-Acetylglucosamine (GlcNAc) Induction of Hyphal Morphogenesis and Transcriptional Responses in Candida albicans Are Not Dependent on Its Metabolism* , 2011, The Journal of Biological Chemistry.

[36]  B. Rosen,et al.  Jen1p: A High Affinity Selenite Transporter in Yeast , 2010, Molecular biology of the cell.

[37]  S. Paiva,et al.  Functional specialization and differential regulation of short-chain carboxylic acid transporters in the pathogen Candida albicans , 2009, Molecular microbiology.

[38]  H. Yamaguchi,et al.  Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital , 2009, Microbiology and immunology.

[39]  Yusuke Nakamura,et al.  A SNP in the ABCC11 gene is the determinant of human earwax type , 2006, Nature Genetics.

[40]  K. Entian,et al.  The disruption of JEN1 from Candida albicans impairs the transport of lactate , 2004, Molecular membrane biology.

[41]  C. Burkhart,et al.  Cerumen Composition by Flash Pyrolysis-Gas Chromatography/Mass Spectrometry , 2001, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[42]  T. Fujii,et al.  Transport of Pyruvate in Saccharomyces cerevisiae and Cloning of the Gene Encoded Pyruvate Permease , 2000, Bioscience, biotechnology, and biochemistry.

[43]  S. Paiva,et al.  The Lactate-Proton Symport of Saccharomyces cerevisiae Is Encoded by JEN1 , 1999, Journal of bacteriology.

[44]  H. Brinkmeier,et al.  Intracellular calcium chelator BAPTA protects cells against toxic calcium overload but also alters physiological calcium responses. , 1997, Cell calcium.

[45]  B. Bingham,et al.  The organic composition of earwax. , 1991, The Journal of otolaryngology.

[46]  P. Wertz,et al.  Composition of cerumen lipids. , 1990, Journal of the American Academy of Dermatology.

[47]  B. Lindblad Protamine sulphate: a review of its effects: hypersensitivity and toxicity. , 1989, European journal of vascular surgery.

[48]  M. Nakamura,et al.  Effect of thallium acetate on the growth of bacteria. , 1969, The Kurume medical journal.

[49]  T. Danowski,et al.  Thiourea and the inhibition of growth of fungi. , 1948, The Journal of infectious diseases.